Mesosil Secures $2.2 Million to Develop Infection-Fighting Biomaterials for Medical Devices

Toronto-based nanotechnology start-up, Mesosil, has closed $2.2 million CAD in Seed funding to ramp up its production and fuel its commercialization plans. Spun out of the University of Toronto, Mesosil is developing nanometre-scale, silica-based additives designed to prevent infection and disease at the tissue-biomaterial level and extend the lifespan of dental and medical devices like fillers and implants.

Mesosil is an OBIO® member and an alumnus of our BDSP™ and WiHI programs.